Cellipont Bioservices Reaches 100 GMP Batch Releases at Texas Cell Therapy Facility
- Cellipont Bioservices completed its 100th GMP batch release at its The Woodlands, Texas facility approximately one year after launching GMP operations in June 2025.
- The milestone demonstrates operational scale in cell therapy manufacturing, supported by cross-functional teams across manufacturing, quality, supply chain, and validation functions.
Operational Impact
Cellipont's 100-batch milestone at its Texas facility demonstrates proven cell therapy GMP manufacturing capacity and operational maturity, relevant for sponsors evaluating CDMO partners for clinical and commercial cell therapy programs.
Source: PharmaSource RSS